BrainChild Bio advancing BCB-276 towards BLA submission with a single pivotal Phase 2 trial planned to commence in Q4 2025 SEATTLE & CAMBRIDGE, Mass.--(BUSINESS WIRE)--BrainChild Bio, Inc., a clinical ...
Detailed price information for Iovance Biotherapeutics Inc (IOVA-Q) from The Globe and Mail including charting and trades.
Researchers at Oregon Health & Science University have identified a previously unknown system inside cells that works like internal “trade winds,” rapidly carrying essential proteins to the cell’s ...
Cellino Biotech, which was founded in 2017, won a federal grant worth up to $25 million to continue to develop its advanced biomanufacturing technology. Dubbed NEBULA, the system aims to scale the ...
The drug is under Priority Review by the U.S. Food and Drug Administration (FDA) and has a Prescription Drug User Fee Act (PDUFA) date of June 23, 2025 The materials will be made available in the ...
Murad Mamedov, Ph.D., brings expertise in unique, unconventional T cells to advance new cancer immunotherapies.
Dr. Yuelei Shen, President and CEO of Biocytogen, said, “We are thrilled to partner with Moonlight Bio, a pioneering leader in advanced cell therapies. This strategic collaboration leverages our ...
3D organoid models are enabling researchers to advance their understanding of disease biology through the flexibility of in vitro models that more closely reflect in vivo biology. 2D cell models have ...
Researchers are cultivating human brain cells in laboratories to transform them into biological circuits for supercomputers—a field known as “bio computing.” While it sounds like science fiction, ...
Whole-genome and transcriptome landscape of actionable driver-negative lung adenocarcinoma. Efficacy comparison in patients with low TPS (< 50%)/high IC score (≥ 1). Nivolumab plus ipilimumab-based ...
An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators ...